Freezing causes the water to expand, potentially damaging the peptide structure
Mercks Capvaxive is formulated to cover pneumococcal strains responsible for approximately 84% of invasive pneumococcal disease
BLA for Rockets LAD-I Gene Therapy Under Review by FDA Again October 14, 2025 The FDA has accepted Rocket Pharmaceuticals resubmission of a BLA for marnetegragene autotemcel (RP-L201, to be marketed as Kresladi), a genetically modified autologous hematopoietic stem cell therapy intended to treat LAD-I
Anti-Aging Effects Promotes collagen production, reducing fine lines and wrinkles for firmer, more youthful skin
ControlledRelease Capsules
The medication further slows gastric emptying, which could exacerbate pre-existing motility issues